Follow The Filings

TLRY Tilray Brands

Tilray Brands earnings company data as of 5:03 PM ET 10/23

  • 0 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q4 11 Jan EPS -0.19 — —
Rev $265.0M — —
FY2027 Q1 8 Oct EPS -0.18 -0.32 Miss
Rev $266.3M $257.0M Miss -3.5%

Insider trades

Open-market buys and sales by TLRY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TLRY insider trades
  • $69K bought by 3 insiders
  • $233K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Mitchell Gendel Global General Counsel
    Buy
    $11K 2,500 shares at $4.43 +2% to stake
    Traded Aug 6 Filed Aug 7
    ↗
  2. Carl A Merton CFO
    Buy
    $46K 10,000 shares at $4.62 +7.7% to stake
    Traded Aug 4 Filed Aug 4
    ↗
  3. Denise M Faltischek Chief Strategy Officer
    Buy
    $12K 2,500 shares at $4.78 +1.8% to stake
    Traded Aug 3 Filed Aug 4
    ↗
  4. David G. Hopkinson Director
    Sale
    $233K 33,556 shares at $6.94 100% of stake
    Traded Apr 21 Filed Apr 22
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 option exercises and 19 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
10-Q FORM 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 3.02 Filing Doc
8-K 3.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K FORM 10-K Filing Doc
8-K 3.02 Filing Doc
8-K 3.02 Filing Doc
424B7 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 3.02 Filing Doc
8-K 1.01,9.01 Filing Doc
424B5 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 1.01,2.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 3.03,5.03,8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.